FDA warning hurts Hikma generics margins

Thu May 17, 2012 12:33pm IST

Related Topics

Stocks

   

(Reuters) - Hikma Pharmaceuticals Plc said it expects profitability in its generics business to be hurt by continuing price competition and steps it has taken to comply with a warning letter from U.S. regulators.

In February, the company received a warning letter from the U.S. Food and Drugs Administration (FDA) about operations at its Eatontown oral dosage facility in New Jersey. Hikma said it was enhancing its processes to address the regulator's observations but the actions would slow sales in the first half.

"The slower start in 2012 will impact profitability in the first half and we now expect the full year adjusted EBIT margin to be in the mid single-digits," the company said in the portion of an interim statement that referred to its generics business.

For the full year, the company expects to record generic drugs sales of between $130 million-$135 million, with sales strengthening in the second half.

This marks a 13 percent drop from the $154.8 million in sales the generics business reported last year.

However, the company, which also sells branded drugs, stood by its guidance for overall revenue growth of around 20 percent as it expects double-digit revenue growth in its branded and injectables segments to soften the impact of falling generics sales.

Branded drugs contributed the most to the company's revenue last year.

Shares in Hikma closed at 613.5 pence on Wednesday on the London Stock Exchange.

(Reporting by Abhishek Takle in Bangalore; Editing by Andrew Callus)

FILED UNDER:
Photo

After wave of QE, onus shifts to leaders to boost economy

DAVOS, Switzerland - Central banks have done their best to rescue the world economy by printing money and politicians must now act fast to enact structural reforms and pro-investment policies to boost growth, central bankers said on Saturday.

Reuters Showcase

Climate Change

Climate Change

U.S.-China climate deal does not put pressure on India, says Modi  Full Article 

Bangladesh Politics

Bangladesh Politics

Bangladesh charges opposition chief with instigating attack on bus  Full Article 

Ukraine Crisis

Ukraine Crisis

Rebels press Ukraine offensive, Obama promises steps against Russian-backed "aggression"  Full Article 

Australian Open

Australian Open

Sweet revenge for Murray as old guard hold firm   Full Article 

Box Office

Box Office

Eastwood's "American Sniper" continues as U.S. box office juggernaut   Full Article 

Boko Haram Fight

Boko Haram Fight

Nigeria repels suspected Boko Haram attack on Maiduguri city  Full Article 

Movie Review

Movie Review

Dolly ki Doli is a breezy watch, writes Shilpa Jamkhandikar.  Full Article | Related Story 

Akshay Kumar's Latest

Akshay Kumar's Latest

"Baby" is a smartly written, well-acted film  Full Article 

Reuters India Mobile

Reuters India Mobile

Get the latest news on the go. Visit Reuters India on your mobile device  Full Coverage